Evogene收到纳斯达克通知

2026-04-03 04:09

Evogene Ltd. (NASDAQ: EVGN) said on Thursday it had received a notice from the Nasdaq indicating that it had fallen out of compliance with Nasdaq Rule 5550(a)(2) after its shares had closed below $1.00 for 30 consecutive business days.
The company said it had until September 28, 2026, to regain compliance, requiring its shares to close at or above $1.00 for at least 10 consecutive business days within the 180-day period.
If it had not regained compliance by September 28, 2026, Nasdaq would have notified it that its shares were subject to delisting.
The company said maintaining its Nasdaq listing had remained a priority and that it had planned to consider options, including a potential reverse stock split, to regain compliance.
Shares -3.16%.

More on Evogene